1ST Biotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate FB849 in Combination With KEYTRUDA® (pembrolizumab)
19. September 2023 04:00 ET
|
AKAMPION
YONGIN, South Korea, September 19, 2023 -- 1ST Biotherapeutics, Inc., a clinical-stage biotechnology company focused on the development of novel small molecule therapeutics in neurodegenerative...
ImmunOs Therapeutics Appoints Dr. Constanze Guenther as Senior Vice President, CMC and Technical Development
19. September 2023 04:00 ET
|
AKAMPION
- Former Novartis Executive Director brings significant expertise in manufacturing, operations, and technical development Schlieren (Zurich Area), Switzerland, and Gaithersburg, MD, USA –...
Thermosome Establishes High-Profile Clinical Advisory Board
19. September 2023 04:00 ET
|
AKAMPION
Leveraging the transformative potential of TSL-based tumor targeting Supporting the progress of Thermosome's clinical candidate THE001 Munich, Germany – September 19, 2023 – Thermosome, a drug...
BellaSeno Reports Positive One-Year Patient Follow-Up Data for Resorbable Breast and Pectus Excavatum Scaffolds
05. September 2023 04:00 ET
|
AKAMPION
Key milestone for novel, resorbable breast / pectus reconstruction implants Leipzig, Germany, September 5, 2023 – BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable...
BellaSeno Granted Market Access in Europe for Custom-Made Bone and Pectus Excavatum Scaffolds
06. Juli 2023 04:00 ET
|
AKAMPION
Market entry under new EU regulations for medical devicesSpearheading the commercialization of 3D-printed regenerative medicine products Leipzig, Germany, July 6, 2023 – BellaSeno GmbH, an ISO...
TolerogenixX expands Phase II immune-tolerance trial and closes EUR 12 million Series A financing
06. Juli 2023 04:00 ET
|
AKAMPION
Ongoing Phase IIb study expands to arm B5-year results of phase I study confirm efficacy and safety of novel immune-tolerance inducing cell therapy in organ transplantationSecond closing of Series A...
Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program
05. Juli 2023 04:00 ET
|
AKAMPION
- Cellbox Solutions selected by the EIC following the second 2023 EIC Accelerator cut-off PRESS RELEASE. Cologne, Germany — July 05, 2023 - Cellbox Solutions GmbH, a leading provider of warm...
Oliver Healthcare Packaging stärkt seine Lieferkette und erweitert regionale Film- und Folienproduktion
29. Juni 2023 03:00 ET
|
AKAMPION
-- Übernahme von EK-Pack stellt die neueste Investition zur Stärkung des Engagements für Kunden in ganz Europa dar. Philadelphia, USA, und Wiggensbach, Deutschland (29. Juni 2023) - Oliver...
Oliver Healthcare Packaging Strengthens Supply Chain, Adds In-Region Film & Foil Production
29. Juni 2023 03:00 ET
|
AKAMPION
-- Acquisition of EK-Pack latest investment to bolster commitment to customers throughout Europe. Philadelphia, United States, AND Wiggensbach, Germany (29 June 2023) – Oliver Healthcare...
Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are Active
28. Juni 2023 04:00 ET
|
AKAMPION
- First-in-human clinical trial of MyopiaX®, the first therapeutic approach in juvenile myopia to target the dopamine pathway digitally- Enrollment ongoing in Germany, Spain, the Netherlands, and the...